QPP Measure #481
Intravesical Bacillus-Calmette Guerin for Non-muscle Invasive Bladder Cancer
Percentage of patients initially diagnosed with non-muscle invasive bladder cancer and who received intravesical Bacillus-Calmette-Guerin (BCG) within 6 months of bladder cancer staging.
Submission Methods: Electronic Health Record
Measure Sets: Urology
Thank you for choosing Find-A-Code, please Sign In to remove ads.